Bionorica (Beijing) Technology Development Co., Ltd.

Bionorica, a German company, is the world's leading manufacturer of natural medicines. Its headquarters is located in Bavaria, Germany, and its wholly-owned subsidiaries and offices are distributed in dozens of countries around the world, including the United States, China, Japan, Russia, and most European countries.

Bionorica has a research and development team that is second to none in the field of phytomedicine globally. Through cooperation with top universities and research institutions worldwide, the company continuously enhances its scientific and technological innovation capabilities. In addition to Germany, it has also established leading phytomedicine research and development centers in Austria and the United States.

Currently, Bionorica AG is one of the world's leading providers of phytotherapeutic drugs. Its products have been used for 75 years. The company's CEO, Professor Michael Popp, is a third-generation member of the founding family. The company's products mainly focus on respiratory, gynecological, and immune system areas. Among them, Sinupret has been marketed in more than 50 countries worldwide, including most European, Asian, and African countries. Its sales rank first in the German OTC market, and it also holds a leading position among similar products in Europe. It entered China in 2003 with favorable market response. Bronchipret, as the company's second flagship product, has been successfully validated in multi-center clinical trials in Europe and America, a first among similar phytomedicines worldwide.

Bionorica (Beijing) Technology Development Co., Ltd. is a wholly-owned subsidiary of Bionorica in China, dedicated to better expanding the Chinese market. Currently, this subsidiary is in a stage of continuous growth.